R. Vera García

Patient profiles as an aim to optimize selection in the second line setting: the role of aflibercept

A. Fernández Montes, E. Aranda Aguilar, P. García-Alfonso, 2021, Clinical and Translational Oncology.

European practice patterns and barriers to smoking cessation after a cancer diagnosis in the setting of curative versus palliative cancer treatment.

H. Minn, G. Warren, M. Borner, 2020, European journal of cancer.

TESEO, cancer-associated thrombosis registry from the Spanish Society of Medical Oncology (SEOM)

A. M. Muñoz Martín, P. Jiménez-Fonseca, A. Carmona-Bayonas, 2019, Clinical and Translational Oncology.

Quality of life assessment through the EORTC questionnaires of locally advanced rectal cancer patients treated with preoperative chemo-radiotherapy

F. Arias de la Vega, M. M. Aguillo, A. M. Burgaleta, 2006, Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico.

New clinical trials regulation in Spain: analysis of royal decree 1090/2015

R. García-Campelo, E. González-Flores, M. Martín Jiménez, 2016, Clinical and Translational Oncology.

Complementary medicine use in cancer patients receiving intravenous antineoplastic treatment.

R. Juanbeltz Zurbano, R. Vera García, Susana de la Cruz Sánchez, 2017, Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria.